Thus, our finding shows that both NS3- and NS5-specific TCR-T cells trigger an HLA-A2-restricted antiviral response against HCV replicon in hepatoma cell line in a 2D culture model. The gene discussed is KRAS; the disease is hepatocellular carcinoma.